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Abstract 29 
The neural crest (NC) is a multipotent embryonic cell population generating distinct cell types 30 
in an axial position-dependent manner. The production of NC cells from human pluripotent 31 
stem cells (hPSCs) is a valuable approach to study human NC biology. However, the origin 32 
of human trunk NC remains undefined and therefore current in vitro differentiation strategies 33 
induce only a modest yield of trunk NC cells. Here we show that hPSC-derived axial 34 
progenitors, the posteriorly-located drivers of embryonic axis elongation, give rise to trunk 35 
NC cells and their derivatives. Moreover, we define the molecular signatures associated with 36 
the emergence of human NC cells of distinct axial identities in vitro. Collectively, our findings 37 
indicate that there are two routes toward a human post-cranial NC state: the birth of cardiac 38 
and vagal NC is facilitated by retinoic acid-induced posteriorisation of an anterior precursor 39 
whereas trunk NC arises within a pool of posterior axial progenitors. 40 
 41 
Introduction 42 
The neural crest (NC) is a multipotent cell population which arises in the dorsal neural 43 
plate/non-neural ectoderm border region during vertebrate embryogenesis. Studies utilising 44 
chick and amphibian embryos have indicated that different levels of BMP, WNT and FGF 45 
signals, emanating from the mesoderm/non-neural ectoderm, orchestrate NC induction and 46 
specification (1). This occurs via the action, first of neural plate border-specific transcription 47 
factors such as PAX3/7, MSX and ZIC family members, and then via definitive NC-specifiers 48 
(e.g. SOX9/10) (2). Once specified, NC cells undergo epithelial-to-mesenchymal transition 49 
(EMT), exit the neural tube, and migrate to generate various cell types. The identity of NC 50 
products correlates to their position along the anteroposterior (A-P) axis, which is in turn 51 
reflected by the expression of paralogous HOX gene groups. Cranial NC cells give rise to 52 
mesoectodermal derivatives (e.g. dermis, cartilage, bone), melanocytes, neurons and glia 53 
colonizing the head (3) and are divided into an anterior HOX-negative and a posterior HOX 54 
group(1-3)-positive domain. The latter also includes cells contributing to heart structures 55 
(termed cardiac NC) (3, 4). Vagal NC cells, which are located between somites 1-7, are 56 
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marked by the expression of HOX group(3-5) members (5-7) and generate the enteric 57 
nervous system (ENS) (8). HOX group(5-9)-positive NC cells at the trunk level (5, 9-11) 58 
produce sympathoadrenal cells, which in turn give rise to sympathetic neurons, 59 
neuroendocrine cells, and melanocytes (12).  60 
 An attractive approach for studying human NC biology and modelling NC-associated 61 
developmental disorders (neurocristopathies) involves the in vitro differentiation of human 62 
pluripotent stem cells (hPSCs) toward NC cells. Conventional protocols to obtain NC from 63 
hPSCs are conceptually based on the production of a neurectodermal intermediate, via 64 
TGFβ signalling inhibition, which is subsequently steered toward a NC fate, usually through 65 
stimulation of WNT activity combined with the appropriate BMP level (13-16). These 66 
strategies yield NC cells of an anterior cranial character lacking HOX gene expression and 67 
the generation of more posterior HOX+ NC subtypes typically relies on the addition of 68 
retinoic acid (RA) and/or further WNT signalling stimulation (17-20). However, these signals 69 
fail to efficiently induce a high number of NC cells of a HOX(5-9)+ trunk identity from an 70 
anterior cranial progenitor. Therefore, the generation of trunk NC derivatives such as 71 
sympathoadrenal cells often requires the flow cytometry-based purification of small cell 72 
populations positive for lineage-specific fluorescent reporter (18) or cell surface markers 73 
(21), a time-consuming and laborious approach.  74 
A number of studies in chicken and mouse embryos employing both fate mapping 75 
and lineage tracing have shown the existence of a posterior NC progenitor entity, which is 76 
distinct from its more anterior counterparts and potentially co-localises with a pool of 77 
caudally-located axial progenitors (22-27) . These progenitors include a bipotent stem cell-78 
like population that fuels embryonic axis elongation through the coordinated production of 79 
spinal cord neurectoderm and paraxial mesoderm (PXM) (28) (reviewed in (29) and (30). In 80 
both mouse and chick embryos these neuromesodermal progenitors (NMPs) are located in 81 
the node/streak border and the caudal lateral epiblast during early somitogenesis, and later 82 
in the chordoneural hinge within the tailbud (TB) (27, 31-34). No unique NMP markers have 83 
been determined to date and thus phenotypically NMPs are defined by the co-expression of 84 
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the pro-mesodermal transcription factor Brachyury (T) and neural regulator SOX2 (35-37). 85 
Furthermore, they express transcripts which are also present in the primitive streak (PS) and 86 
TB marking committed PXM and posterior neurectodermal progenitors such as Cdx and Hox 87 
gene family members, Tbx6 and Nkx1-2 (23, 24, 31, 38, 39). T and SOX2 have a critical 88 
role, in conjunction with CDX and HOX proteins, in regulating the balance between NMP 89 
maintenance and differentiation by integrating inputs predominantly from the WNT and FGF 90 
signalling pathways (27, 38-41). The pivotal role of these pathways has been further 91 
demonstrated by recent studies showing that their combined stimulation results in the robust 92 
induction of T+SOX2+ NMP-like cells from mouse and human PSCs (42-44).  93 
NMPs/axial progenitors appear to be closely related to trunk NC precursors in vivo. 94 
Specifically, trunk NC production has been shown to be controlled by transcription factors 95 
which also regulate cell fate decisions in axial progenitors such as CDX proteins (45-47) and 96 
NKX1-2 (48). The close relationship between bipotent axial and posterior NC progenitors is 97 
further supported by fate mapping experiments involving the grafting of a portion of E8.5 98 
mouse caudal lateral epiblast T+SOX2+ cells (27) and avian embryonic TB regions (22, 34)  99 
as well as lineage tracing experiments (23, 24) which have revealed the presence of cell 100 
populations exhibiting simultaneously mesodermal, neural and NC differentiation potential.  101 
Together these findings suggest that the trunk/lumbar NC is likely to originate from a subset 102 
of axial progenitors arising near the PS/TB. 103 
Here we sought to determine whether trunk NC is also closely related to axial 104 
progenitors in the human and thus define a robust improved protocol for the production of 105 
trunk NC cells and their products from hPSCs. We show that hPSC-derived, “pre-neural” 106 
axial progenitors contain a subpopulation that displays a BMP-dependent, mixed early 107 
NC/NMP transcriptional signature and thus is likely to represent the earliest trunk NC 108 
precursors. We demonstrate that neuromesodermal-potent axial progenitor cultures are 109 
competent to generate efficiently trunk NC cells, marked by thoracic HOX gene expression. 110 
This transition to trunk NC appears to take place via the maintenance of a CDX2/posterior 111 
HOX-positive state and the progressive amplification of an NC gene regulatory network.  We 112 
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also show that “caudalisation” via RA treatment of anterior NC precursors leads to the 113 
acquisition of a mixed cardiac and vagal NC identity rather than a trunk NC character and 114 
define novel markers of distinct posterior NC subtypes. Finally, we utilise our findings to 115 
establish a protocol for the in vitro generation of PHOX2B+ sympathoadrenal cells and 116 
sympathetic neurons at high efficiency from cultures of posterior axial progenitor-derived 117 
trunk NC cells without the need for FACS-sorting to select for minor precursor 118 
subpopulations. Taken together these findings provide an insight into the mechanisms 119 
underpinning the “birth” of human NC cells at different axial levels and pave the way for the 120 
modelling of trunk NC-linked diseases such as neuroblastoma. 121 
 122 
Results 123 
Transcriptome analysis of human axial progenitors 124 
We and others have previously shown that combined stimulation of the WNT and FGF 125 
signalling pathways in PSCs leads to the production of a high (>80%) percentage of 126 
T+SOX2+ cells. The resulting cultures resemble embryonic posterior axial progenitors, 127 
including NMPs, both in terms of marker expression and developmental potential (38, 42-44, 128 
49). To interrogate the transcriptome changes associated with the induction of such 129 
progenitors in a human system and identify the presence of trunk NC precursors, we carried 130 
out RNA sequencing (RNAseq) following 3-day treatment of hPSCs with recombinant FGF2 131 
and the WNT agonist/GSK-3 inhibitor CHIR99021 (CHIR). As reported previously, most cells 132 
emerging under these conditions co-expressed T and SOX2 as well as CDX2 (Figure 1A). 133 
We found that the transcriptomes of hNMPs and hPSCs were markedly distinct from each 134 
other (Figures S1A, S1B) and dramatic global gene expression changes accompanied the 135 
acquisition of an axial progenitor character: 1911 and 1895 genes were significantly 136 
(padj<0.05; Fold Change >= 2) up- and down-regulated compared to hPSCs respectively 137 
(Table S1). Predictably, the top-downregulated genes were associated with undifferentiated 138 
hPSCs (e.g. NANOG, GDF3, POU5F1), anterior neurectoderm (OTX2) and lateral/ventral 139 
mesoderm (KDR). The vast majority of the top-upregulated genes were well-established 140 
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drivers of axis elongation (e.g. TBRA, CDX1/2, EVX1, MSGN1, TBX6) and 141 
WNT/FGF/NOTCH/RA signalling pathway components, known to be expressed at high 142 
levels in the late PS/TB regions in vivo (e.g. WNT3A/5B, RSPO3, FGF4/8, FGF17, HES7) 143 
(Figures 1B, S1C, S1D, Table S1).  A large fraction of upregulated genes were 144 
transcriptional regulators (Figure S1D, Table S1) and we found that members of HOX gene 145 
clusters belonging to paralogous groups 1-9 were strongly differentially expressed between 146 
the two groups (Figure 1C, S1E, Table S1). The upregulation of posterior thoracic (group 5-147 
9) HOX transcripts as well as the presence of many transcripts (23/32) marking “late” E9.5 148 
mouse embryonic NMPs such as CYP26A1, FGF17 and WNT5A (38) suggest that day 3 149 
WNT-FGF-treated hPSC cultures may correspond to a more developmentally advanced 150 
axial progenitor state. Overall, these data confirm our previous observations that treatment 151 
of hPSCs with WNT and FGF agonists gives rise to cultures resembling embryonic posterior 152 
axial progenitors.   153 
 154 
A BMP-dependent neural crest signature in human axial progenitor cultures 155 
We next sought evidence pointing to the potential links between trunk NC and human axial 156 
progenitors. The RNAseq analysis revealed that a considerable number of genes known to 157 
collectively mark the neural plate border and early NC in vivo (“NC/border” e.g. SOX9, 158 
PAX3, MSX1/2, SNAI1/2, ZIC1/3) were also significantly upregulated in axial progenitors 159 
(Figure 2A), a finding which was further verified using quantitative real time PCR (qPCR) 160 
(Figure S2A). To exclude the possibility that the presence of such markers was the result of 161 
spontaneous differentiation of NM bipotent axial progenitors and their neural derivatives we 162 
examined their co-expression with T, a marker of both NMPs and prospective PXM. 163 
Immunostaining of  d3 WNT-FGF-treated hPSC cultures showed that a considerable fraction 164 
of T+ cells also expressed the early NC markers/specifiers SOX9, SNAI2 and PAX3 (Figure 165 
2B). Moreover, SOX9-positive cells were found to express low or no MSGN1 or TBX6 166 
(Figure S2B) suggesting that the upregulation of border/NC markers following WNT-FGF 167 
treatment of hPSCs was unlikely to reflect the presence of committed PXM cells given that 168 
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some of these genes are also expressed in the mesoderm during axis elongation. 169 
Collectively, these findings indicate that a NC/border state probably arises within multipotent 170 
posterior axial progenitors which have not committed to a neural or mesodermal fate. 171 
A number of both in vivo and in vitro studies have pointed to an optimal level of 172 
low/intermediate BMP signalling acting as an inducer of a NC/border character in 173 
conjunction with WNT and FGF (14, 16, 48, 50-53). We therefore examined whether hPSC-174 
derived axial progenitor cultures exhibit endogenous BMP activity. RNAseq revealed that 175 
many BMP pathway -associated transcripts (BMP2/4/6/7 and ID1/4) were significantly 176 
upregulated compared to hPSCs (Figure 2A). Moreover, antibody staining showed 177 
expression of phosphorylated SMAD1/5, a readout of BMP activity (Figure 2C). This is 178 
extinguished upon treatment with the BMP antagonist LDN193189 (LDN) (54) during the in 179 
vitro differentiation of hPSCs to day 3 axial progenitors (Figure 2C). Interestingly, BMP 180 
inhibition also caused a decrease in the transcript levels of most border/NC-specific 181 
transcripts with PAX3 and MSX1 being the most severely affected (Figure 2D). We also 182 
observed a reduction in the NMP/late PS/TB markers CDX2 and WNT3A whereas the PXM 183 
specifier TBX6 remained relatively unaffected by LDN treatment suggesting that emergence 184 
of prospective PXM is not influenced by BMP inhibition (Figure 2D). By contrast, SOX2 185 
expression was markedly increased upon LDN treatment (Figure 2D). Taken together these 186 
data indicate a correlation between endogenous BMP activity and the acquisition of a 187 
SOX2+low border/NC identity by posterior axial progenitors while transition toward a SOX2+ 188 
high neural fate relies on BMP antagonism in vitro. 189 
 190 
In vitro-derived axial progenitors are a source of trunk neural crest cells 191 
We reasoned that if posterior axial progenitors with border/NC features correspond to 192 
pioneer trunk NC precursors then they should be competent to generate definitive trunk 193 
neural crest when placed in the right culture environment. We have recently reported a 194 
protocol for the efficient generation of anterior cranial NC cells from hPSCs involving the 195 
combined stimulation of WNT signalling, TGFβ signalling inhibition and moderate BMP 196 
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activity via the parallel addition of BMP4 and the BMP type 1 receptor inhibitor DMH1 (16). 197 
Culture of day 3 WNT-FGF-treated hPSCs under these NC-inducing conditions for 5-6 days 198 
gave rise to a high number (average percentage=50% of total cells)  of cells co-expressing 199 
the definitive NC marker SOX10 together with HOXC9, a readout of trunk axial identity 200 
(Figure 3A, 3B, 3C). A large proportion of the cultures were also SOX9+HOXC9+ further 201 
confirming an trunk NC character whereas the percentage of neural cells marked by SOX1 202 
expression remained very low throughout the course of the differentiation (Figure 3B, S3A, 203 
S3B). This may indicate that posterior NC progenitors do not progress through neural 204 
commitment but rather diverge from an earlier pre-neural, border-like stage reflecting 205 
previous reports which show that NC specification takes place prior to definitive neurulation 206 
(48, 55, 56). Furthermore, during the transition toward trunk neural crest, the NMP/pre-207 
neural marker NKX1-2 was rapidly extinguished followed shortly after by T, while CDX1 208 
transcript levels declined more slowly (Figure S3A, S3B). By contrast, the expression of 209 
CDX2 and SOX9 was maintained at high levels (>70% of total cells) throughout the course 210 
of differentiation of axial progenitors to trunk NC while SOX10 expression appeared only 211 
after day 7 of differentiation (Day 0 defined as the start of axial progenitor induction from 212 
hPSCs) (Figure S3C, data not shown). We also confirmed the NM potency of the starting 213 
axial progenitor cultures as treatment with high levels of FGF2/CHIR and RA led to the 214 
production of TBX6+ PXM and SOX1+ spinal cord, posterior neurectoderm (PNE) cells 215 
respectively (Figure 3A, 3D). Taken together these data suggest that hPSC-derived NM-216 
potent axial progenitor cultures are competent to produce trunk NC at high efficiency.  217 
Similar to popular in vitro neural induction strategies, most current NC differentiation 218 
protocols aiming to generate posterior (e.g. trunk) cell populations from hPSCs rely on the 219 
caudalisation of an anterior ectodermal precursor via treatment with RA and/or WNT 220 
agonists (15, 17-20). Therefore, we compared our axial progenitor–based approach for 221 
generating trunk NC to a conventional strategy involving the generation of anterior cranial 222 
NC (ANC) precursor cells (16) followed by RA addition in the presence of WNT and BMP 223 
signalling (Figure 4A). The axial identity of the resulting cells was assessed by qPCR assay 224 
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of HOX transcripts corresponding to different levels along the A-P axis. In line with previous 225 
findings (17, 19) RA-treated cells expressed high levels of HOX group 1-5 members 226 
compared to untreated NC suggesting a posterior cranial and vagal/cardiac NC character 227 
(Figure 3E). However, efficient induction trunk of HOXC8 and 9 transcripts was only 228 
achieved when posterior axial progenitors were employed as the starting population for NC 229 
generation (Figure 3E). Furthermore, axial progenitor-derived NC cells were marked by 230 
increased expression of the trunk NC marker HES6, but did not express the cranial markers 231 
OTX2,  DMBX1 and LHX5 although they were positive for the “late” cranial NC transcripts 232 
(TFA2B, ETS1, SOX8) (57) (Figure 3F). We thus conclude that posterior axial progenitors 233 
are the ideal starting population for efficiently generating trunk NC in vitro whereas RA 234 
treatment of anterior NC precursors predominantly produces posterior cranial and 235 
cardiac/vagal NC cells. These data also serve as evidence supporting the notion that trunk 236 
NC precursors are likely to arise within cells with axial progenitor/NMP features rather than a 237 
caudalised anterior progenitor. 238 
 239 
Efficient A-P patterning of human neural crest cells reveals molecular signatures of 240 
distinct axial identities 241 
To further discern the identity of posterior NC subtypes induced either via RA treatment or 242 
an axial progenitor intermediate as well as identify unique associated molecular signatures 243 
we carried out analysis of the transcriptomes of NC cells arising under these conditions as 244 
well as those of their precursors using microarrays (Figure 4A). We found that axial 245 
progenitor-derived NC cells (NMP-NC d9) and their precursors (NMP-NC d6) grouped 246 
together and were distinct from a cluster containing d6 anterior cranial NC (ANC) and +RA 247 
NC cells and their common d3 progenitor (ANC d3) (Figure 4B, S4A). Although the three 248 
final populations exhibited distinct transcriptional profiles they all expressed pan-NC genes 249 
including “early” NC/border (MSX1/2, PAX3/7) and “late” NC (SOX10, SNAI1/2) transcripts 250 
(Figure 4C, S4B, S4C, Table S2). In line with our previous observations (Figure 3C), ANC 251 
cells failed to express any HOX transcripts, RA treatment induced anterior HOX genes and 252 
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only WNT-FGF-treated hPSCs gave rise to NC cells positive for thoracic HOX group (5-9) 253 
members (Figure 4D) reflecting an anterior cranial, posterior cranial/cardiac/vagal and trunk 254 
NC fate respectively. The axial identity of the resulting posterior NC subtypes was further 255 
confirmed by the observation that some of the most-upregulated transcripts in +RA cells 256 
were established posterior cranial (e.g. ALX1/3 (58)), cardiac (e.g.  FOXC1 and 2 (59); 257 
PDGFRa (60); TBX2/3 (61)) and vagal/enteric NC markers (PHOX2A (62); KITLG (63); 258 
ARPC1B (64) (Figure 4E). In contrast, known trunk NC, sympathoadrenal and 259 
sympathetic/sensory neuron regulators such as CDX2 (47), INSM1 (65), ISL1 (66) and 260 
NEUROG1 (67) were induced only in NC cells derived from axial progenitors (Figure 4F, 261 
Table S2). We also identified ASLX3, the human homologue of the Drosophila polycomb 262 
protein asx (68) which has been recently linked to the developmental syndrome Bainbridge-263 
Ropers (69) as a novel trunk NC marker (Figure 4F, Table S2). Transcription factors 264 
specifically induced in anterior cranial NC cells included the forkhead gene FOXS1 which 265 
has been shown to be expressed in mouse NC derivatives (70) and TCF7L2, a WNT 266 
signalling effector which has been reported to harbour a NC-associated enhancer (71) 267 
(Tables S2, S3). Collectively these data support the idea that a mixed posterior 268 
cranial/vagal/cardiac NC character arises upon treatment of anterior NC precursors with RA 269 
whereas a bona fide trunk NC identity can be achieved only via an axial progenitor 270 
intermediate.   271 
One of the most over-represented gene categories in all three axial NC subtypes 272 
were transcription factors and a common NC-specific transcription factor module was found 273 
to be expressed regardless of axial character (Figure S4B, Table S3, Table S4). This 274 
included well-established border/NC regulators such as PAX3/7, MSX2, SOX9/10, TFAP2A-275 
C and SNAI1/2 (Figure S4C, Tables S3, S4). However, the expression levels of many of 276 
these transcription factors varied between the three groups (Figure S4C). The highest levels 277 
of HES6, FOXD3 and MSX1/2 were found in axial progenitor-derived trunk NC cells whereas 278 
high PAX7 and SNAI1/ SOX9 expression was more prevalent in the anterior cranial and RA-279 
treated samples respectively (Figure S4C).  Comparison of the day 6 trunk and d3 ANC 280 
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precursor transcriptomes also revealed that expression of LHX5 and DMBX1 marks an 281 
anterior NC state whereas HES6 is associated exclusively with a trunk fate (Figure S4D) 282 
indicating that diversification of axial identity in NC cells starts at an early time point via the 283 
action of distinct molecular players.   284 
 285 
Distinct routes to posterior neural crest fates 286 
To identify candidate genes mediating the gradual lineage restriction of trunk NC precursors 287 
present in axial progenitor cultures we compared the transcriptomes of d6 trunk NC 288 
precursors and day 3 WNT-FGF-treated hPSCs (=”NMPs”). We found that dramatic global 289 
gene expression changes take place during the axial progenitor-trunk NC transition (Figure 290 
4G, S4E). Some of the most upregulated transcripts were the NC-specific TFAP2A/B, ETS1, 291 
SOX5 and SOX10  together with the established trunk NC specifier CDX2, the novel trunk 292 
NC marker ASLX3, the nuclear receptors NR2F1/2 and thoracic HOX genes (HOXB7, B9) 293 
(Figure  4G, Table S4). In contrast, signature axial progenitor transcription factors such as 294 
T, MIXL1, NKX1-2, anterior HOX genes (HOXA1/B1) and some WNT signalling components 295 
(WNT8A/5B) were significantly downregulated (Figure 4G, Table S4). Thus differentiation of 296 
trunk NC precursors appears to involve the transition from an axial progenitor-associated 297 
gene regulatory network to a NC-specifying one that incorporates factors which potentially 298 
act as general determinants of posterior cell fate (CDX2, HOXB9). 299 
We also examined transcriptome changes during the transition from an anterior NC 300 
precursor state (ANC d3) to RA-posteriorised vagal/cardiac NC cells (+RA d6). The most-301 
highly induced transcripts in posterior cranial/cardiac/vagal NC cells included the RA 302 
receptors beta and gamma (RARb/g) which have been involved in hindbrain and neural crest 303 
patterning (72) and the T-box transcription factor TBX2, a marker of cardiac NC and in vitro 304 
derived vagal/enteric NC progenitors (19) (Table S4). Other upregulated transcripts included 305 
the planar cell polarity (PCP) component PRICKLE1, a regulator of cardiac NC cell function 306 
(73) and the TGFβ signalling-associated gene TGFBI (Table S4). Anterior NC d3 precursor 307 
specific –transcripts included the border markers PAX7 and ZIC3 as well as the early cranial 308 
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NC transcription factors OTX2 and LHX5 (57) (Table S4). These results indicate that, in 309 
contrast to trunk NC cells, posterior crania/ cardiac/vagal NC cells arise from an anterior 310 
neural plate border precursor through posteriorisation under the influence of RA and possibly 311 
the non-canonical WNT and TGFβ pathways.  312 
 313 
Efficient in vitro generation of sympathoadrenal cells from axial progenitors 314 
We next sought to determine whether trunk NC cells derived from axial progenitors are the 315 
optimal source of sympathoadrenal (SA) progenitors and their derivatives. The BMP and 316 
sonic hedgehog (SHH) signalling pathways have been shown to be critical for the 317 
specification of these lineages from NC cells (74, 75). Therefore we cultured d8 trunk NC 318 
cells generated from axial progenitors carrying a GFP reporter within the SA/sympathetic 319 
neuron regulator PHOX2B locus (18, 76), in the presence of BMP and sonic hedgehog 320 
(SHH) signalling agonists (Figure 5A). GFP expression was assayed after 4 days of culture 321 
of trunk NC cells in BMP4 and SHH agonists (i.e. day 12 of differentiation) (Figure 5B). 322 
FACS analysis revealed that the majority of cells were PHOX2B expressing (average 323 
percentage from four independent experiments=73.5%, s.d.= 6.344)  (Figure 5B) and a 324 
large proportion of them were also positive for the early SA progenitor marker ASCL1 (77) 325 
indicating that they had acquired a symphathoadrenal identity (Figure S5A). Further 326 
maturation of the resulting SA progenitors in the presence of neurotrophic factors (BDNF, 327 
GDNF and NGF) for a further 6-8 days resulted in the induction of a high yield of 328 
sympathetic neurons/progenitors co-expressing PHOX2B together with the sympathetic 329 
neuron regulator GATA3 (78) (average of 40% of total cells), ASCL1 (63%) and the SA 330 
differentiation regulator ISL1 (64%) (Figure 5C, 5D). A high proportion of the resulting cells 331 
also expressed the dopamine production-associated enzyme/sympathetic neuron marker 332 
tyrosine hydroxylase (TH) (79) (Figure 5D). Furthermore, the cultures widely expressed the 333 
peripheral nervous system marker PERIPHERIN (PRPH) (80) together with the trunk axial 334 
marker HOXC9 (Figure S5B). We also detected dramatic induction of GATA3, ASCL1, TH 335 
and PHOX2B transcripts (between 1000 and 1,000,000-fold) as well as other SA lineage 336 
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markers such as GATA2, DBH (dopamine-β-hydroxylase) and to a lesser extent PHOX2A 337 
using qPCR (Figure 5E). Together, these results suggest that the optimal route toward the 338 
efficient production of sympathoadrenal cells and sympathetic neurons from hPSCs relies on 339 
the induction of posterior axial progenitors. 340 
 341 
Discussion 342 
Despite progress in the optimisation of current NC differentiation protocols the in vitro 343 
generation of trunk NC cells from hPSCs remains challenging and requires FACS-sorting of 344 
selected progenitor subpopulations, a time-consuming and laborious process also 345 
associated with increased cell death. This bottleneck prevents the dissection of the 346 
mechanisms directing human NC emergence at different axial levels as well as the efficient 347 
isolation of cell types for modelling trunk NC-specific neurocristopathies such as 348 
neuroblastoma. Previous work in amniote embryos suggested that posterior 349 
(trunk/lumbosacral) NC cells arise independently from their anterior counterparts, within a 350 
pool of axial progenitors localised near the primitive streak and the tailbud during axis 351 
elongation (22, 25-28). Here we utilised these findings and exploited our ability to induce T+ 352 
NM-potent axial progenitors from hPSCs in order to use them as the optimal starting point 353 
for the efficient in vitro derivation of trunk NC (~50% HOXC9+SOX10+), SA progenitors 354 
(~70% PHOX2B-GFP+) and sympathetic neurons without the use of FACS sorting. This 355 
strategy represents a considerable improvement over current approaches, which typically 356 
yield 5-10% PHOX2B-GFP+ cells (18) and is in line with a recent study reporting the 357 
successful production of chromaffin-like cells through the use of an NC-induction protocol 358 
which transiently produces T+SOX2+ cells (20, 21).  359 
We show that, similar to neural cells  a HOX-positive posterior identity is acquired by 360 
human NC cells via two distinct routes: posterior cranial/vagal/cardiac HOX(1-5)+ NC cells 361 
emerge through the RA/WNT-induced posteriorisation of a default anterior precursor, 362 
reflecting Nieuwkoop’s “activation-transformation” model, whereas HOX(5-9)+ trunk NC cells 363 
arise from a separate WNT/FGF-induced posterior axial progenitor exhibiting caudal lateral 364 
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epiblast/NMP features mixed with a BMP-dependent  neural plate border/neural crest 365 
identity (Fig. 6). This finding offers an explanation for the failure of current RA 366 
posteriorisation-based in vitro differentiation protocols (17, 19) to yield high numbers of 367 
HOX9+ trunk NC cells and should serve as the conceptual basis for the design of 368 
experiments aiming to generate NC cells of a defined A-P character from hPSCs. 369 
Our data indicate that a subpopulation of in vitro derived human axial progenitors 370 
acquires border/early NC characteristics in response to the WNT and FGF signals present in 371 
the differentiation culture media, and under the influence of autocrine BMP signalling. This is 372 
in line with bulk and single cell transcriptome data showing that mouse embryonic axial 373 
progenitors/NMPs express border and early NC markers (38, 41). Furthermore, our data 374 
reflect findings in the chick embryo showing that an “unstable”, pre-neural plate border 375 
domain, potentially defined by the co-localisation of pre-neural (Nkx1-2) (81) and border 376 
markers such as Pax3 (82) and Msx1, arises in the avian embryonic caudal lateral epibllast 377 
in response to autocrine BMP, FGF (51) and  possibly WNT signalling (83). We also found 378 
that CDX2 expression is maintained at high levels during the generation of trunk NC 379 
indicating that this transcription factor might be critical in inducing an NC character in axial 380 
progenitors. CDX2 has been shown, together with β-catenin, to bind and activate neural 381 
plate border/early NC specifiers such as MSX1 and ZIC1 (47, 84) and, intriguingly, ChiP-Seq 382 
data from in vitro-derived mouse NMPs have revealed that many border/NC genes are direct 383 
targets of CDX2 often jointly with T (e.g. PAX3, SOX9, ZIC3) (39). Collectively these findings 384 
raise the possibility that β-catenin and CDX2, in conjunction with FGF/BMP signalling, may 385 
be critical for the establishment of a border/NC identity in T+ axial progenitors and further 386 
work is required to test this hypothesis.  387 
We show that BMP/WNT treatment of human axial progenitors promotes the 388 
induction of a definitive trunk NC state. This transition appears to coincide with the 389 
progressive extinction of key axial progenitor genes and their replacement by a battery of 390 
NC-specific transcription factors such as TFAP2B, SOX10, NR2F2 and NR2F1 while the 391 
levels of some “common” axial progenitor-NC markers (e.g. SOX9, PAX3, TFAP2A and 392 
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SNAI2) remain high (Figure 4, S3, Table S4). TFAP2A has been previously reported to act 393 
as a master NC transcription factor whose binding on key enhancers, together with 394 
NR2F1/2, appears to initiate transcription of NC-specific genes (71). This finding raises the 395 
possibility that these transcription factors are the molecular drivers of the transition from an 396 
early posterior axial progenitor state to a lineage-restricted trunk NC fate in response to 397 
BMP/WNT. How is a trunk axial character specified? Our transcriptome analysis data 398 
suggest that a generic trunk identity is first installed during the emergence of multipotent 399 
CDX2+trunk HOX+ axial progenitors under the influence of WNT-FGF activity and then 400 
“converted” into posterior NC through the progressive accumulation of neural plate 401 
border/definitive NC markers within BMP-responsive cells. The posterior character of these 402 
incipient trunk NC precursors and their progeny is likely to be maintained via continuous 403 
CDX2 expression and further potentiation of trunk HOX activities as indicated by the 404 
expression profiles of these genes in both d6 precursor and d9 trunk NC cells (Figure 4, S4, 405 
Tables S2-4) and their reported roles in trunk NC specification. However, other trunk NC-406 
specific regulators may also be involved in this process and loss-/ gain-of-function 407 
approaches are required to dissect their exact involvement in programming trunk identity.    408 
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Figure legends 440 
Figure 1. Transcriptome analysis of in vitro-derived human axial progenitors 441 
(A) Immunofluorescence analysis of expression of indicated markers in day 3 hPSC-derived 442 
axial progenitors. Magnified regions corresponding to the insets are also shown. (B) 443 
Heatmap showing the expression values of selected markers in three independent axial 444 
progenitor and hPSC sample replicates. The expression values (FPKM) were scaled to the 445 
row mean. The color key relates the heat map colors to the standard score (z-score). (C) 446 
Induction of all significantly upregulated HOX transcripts in axial progenitors relative to 447 
hPSCs. Paralogous HOX groups corresponding to different axial levels such as cervical 448 
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(groups 1-4), brachial/thoracic (5-9) and lumbosacral (10-13) are indicated. See also Figure 449 
S1 and Table S1. 450 
Figure 2. hNMP cultures exhibit a BMP-dependent neural crest/border signature 451 
(A) Log-fold induction of representative neural crest/neural plate border and BMP-associated 452 
transcripts in axial progenitors compared to hESCs. (B) Immunofluorescence analysis of 453 
expression of indicated markers in axial progenitos. Magnified regions corresponding to the 454 
insets are also shown. (C) Immunofluorescence analysis of expression of phosphorylated 455 
SMAD1/5 (p-SMAD) in the presence and absence of the BMP inhibitor LDN193189 (LDN). 456 
(D) qPCR expression analysis of indicated markers in axial progenitors in the presence (+) 457 
or absence (-) of LDN. Error bars=S.D. (n=2). In all cases nuclei were counterstained with 458 
DAPI. PXM, paraxial mesoderm; NC, neural crest. See also Figure S2. 459 
Figure 3. In vitro derived axial progenitors generate trunk neural crest efficiently 460 
(A) Diagram depicting the culture conditions employed to direct trunk NC, posterior 461 
neurectoderm (PNE) and paraxial mesoderm (PXM) differentiation from hPSC-derived axial 462 
progenitors. (B) Immunofluorescence analysis of the expression of indicated NC (SOX10, 463 
SOX9) and neural (SOX1) and the thoracic/trunk marker HOXC9 in trunk NC (TNC) cells 464 
derived from axial progenitors after 8 days of differentiation. Magnified regions 465 
corresponding to the insets are also shown. Note that the HOXC9/SOX10 and SOX10/SOX1 466 
image sets correspond to the same cells. (C) Quantitation of cells marked by different 467 
combinations of HOXC9 and SOX10 expression in day 8 trunk NC cultures derived from 468 
axial progenitors following image analysis. Six randomly selected fields (two independent 469 
experiments) were used for analysis (total number of cells scored= 5366, average number of 470 
cells/field=894, error bars=s.d.). (D) Immunofluorescence analysis of TBX6 (left) or SOX1 471 
(right) expression in axial progenitors treated with CHIR-FGF2 (pro-PXM conditions) and RA 472 
(pro-PNE conditions) respectively. (E) qPCR expression analysis of indicated HOX genes in 473 
hPSC-derived anterior cranial (ANC), retinoic acid (RA)-treated NC (+RA), and axial 474 
progenitor-derived NC cells (NMP-NC) relative to hPSCs. Error bars=S.E.M. (n=3). (F) 475 
qPCR expression analysis of indicated NC markers in +RA and axial progenitor-derived NC 476 
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cells relative to untreated anterior cranial NC cells. Error bars=S.E.M. (n=3). See also Figure 477 
S3. 478 
Figure 4. Transcriptome analysis of in vitro derived neural crest cells corresponding 479 
to distinct axial levels 480 
(A) Diagrams showing the culture conditions employed for generating NC cells of distinct 481 
axial identities using hPSCs. Asterisks indicate the timepoints used for sample harvesting 482 
and transcriptome analysis. D, day of differentiation. ANC, Anterior neural crest. (B) Principal 483 
component analysis depicting variance between different samples used for microarray 484 
analysis (timepoints shown in A). (C) Venn diagram showing the overlap between all 485 
significantly upregulated (≥2-fold relative to undifferentiated hESCs, FDR ≤ 0.05) in each 486 
indicated NC group. (D) Log fold induction of HOX genes in indicated NC populations 487 
relative to hPSCs. (E) Log fold induction of representative significantly upregulated (≥2-fold 488 
relative to undifferentiated hPSCs, FDR ≤ 0.05) transcripts marking day 6 RA-treated NC 489 
cells. (F) Log fold induction of representative significantly upregulated (≥2-fold relative to 490 
undifferentiated hPSCs, FDR ≤ 0.05) transcripts marking day 9 axial progenitor-derived NC 491 
cells. (G) Log fold changes in the expression of the most-upregulated and most-492 
downregulated transcripts in day 6 axial progenitor-derived NC precursors compared to d3 493 
hPSC-derived axial progenitors. See also Figure S4, Tables S2, S3, and S4. 494 
Figure 5. Axial progenitor-derived trunk neural crest is an optimal source of 495 
sympathoadrenal cells 496 
(A) Diagram depicting the culture conditions employed to direct axial progenitors (“NMPs”) 497 
toward trunk NC and subsequently sympathoadrenal progenitors (SAP) and sympathetic 498 
neurons. (B) FACS analysis of PHOX2B-GFP expression in SAP cells derived from axial 499 
progenitors as shown in A. Below: Immunofluorescence analysis of PHOX2B-GFP and 500 
PHOX2B protein expression following antibody staining. (C) Quantitation of d18 501 
differentiated cells positive for the indicated markers in relation to PHOX2B-GFP expression 502 
following antibody staining. In each case four randomly selected representative fields were 503 
used to obtain the average number of cells/marker. Total numbers of cells scored: GATA3 504 
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(N=3003), ASCL1 (N=2575), ISL1 (N=2963). (D) Immunofluorescence analysis of PHOX2B-505 
GFP together with the indicated markers in day 18 differentiated SAP/sympathetic neurons 506 
derived from axial progenitors as shown in A. (E) qPCR expression analysis of indicated 507 
SAP/sympathetic neuron markers in d12 and d18 cultures. Error bars=S.E.M. (n=3). See 508 
also Figure S5. 509 
Figure 6. A-P patterning of in vitro derived human NC cells 510 
Diagrammatic model summarising our findings on the in vitro generation of NC subtypes of 511 
distinct A-P identity from hPSCs. Examples of unique genes that were found to mark each 512 
NC population exclusively are shown in red. 513 
 514 
Supplemental Figure Legends 515 
Figure S1 516 
(A) Dendrogram showing the clustering of the individual axial progenitor (NMP) and hESC 517 
sample replicates based on RNAseq expression data. (B) Principal Component Analysis 518 
(PCA) plot indicates a good separation, in terms of gene expression, between the two 519 
conditions and a good replication among samples. ((C) Volcano plot reporting pvalue (y axis) 520 
as a function of log2 fold change (x axis) between the axial progenitor and hPSC groups. 521 
The red dots depict significant genes (pvalue<=0.05). Top differentially expressed 522 
transcriptional regulators of axis elongation and WNT/FGF/NOTCH/RA signalling pathway 523 
components are shown. (D) Top gene ontology groups significantly enriched in axial 524 
progenitors vs hPSCs. (E) Hierarchical clustering heatmap showing the expression values of 525 
HOX genes in axial progenitor and hPSC sample replicates. The expression values (FPKM) 526 
were scaled to the row mean. The color key relates the heat map colors to the standard 527 
score (z-score). 528 
Figure S2.  529 
(A) qPCR expression analysis of indicated NC/border and pluripotency markers in axial 530 
progenitors vs hPSCs. Error bars=S.E.M. (n=3). (B) Immunofluorescence analysis of SOX9 531 
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expression together with MSGN1-VENUS (top) and TBX6 (bottom) in axial progenitors 532 
derived from a MSGN1-VENUS or wild type hPSCs respectively. 533 
Figure S3 534 
(A) Immunofluorescence analysis of indicated markers one (day 4 of differentiation) or two 535 
(day 5 of differentiation) days after re-plating axial progenitors into NC inducing conditions. 536 
(B) qPCR expression analysis of indicated axial progenitor (NMP) and neural markers during 537 
differentiation toward TNC. Error bars=s.e.m. (n=3) (C) Immunofluorescence analysis of 538 
indicated NC markers one (day 4 of differentiation) or two (day 5 of differentiation) days after 539 
re-plating axial progenitors into NC inducing conditions. 540 
Figure S4 541 
(A) Heatmap showing Pearson’s signal correlation between indicated samples. (B) Venn 542 
diagram showing the overlap between transcription factors (TFs) enriched (≥2-fold relative to 543 
undifferentiated hPSCs, FDR ≤ 0.05) in each indicated NC group of distinct axial identity. 544 
The detailed list of all TFs can be found in Table S3. (C) Heatmap showing relative 545 
expression of representative NC markers in NC populations of distinct axial identity and 546 
hPSCs. (D) Heatmap showing relative expression of representative NC markers in trunk and 547 
anterior cranial NC precursors and hPSCs. (E) Volcano plot depicting upregulated (red) and 548 
downregulated (green) genes in d6 trunk NC precursors (NMP-NC) vs axial progenitors 549 
(=NMPs). 550 
Figure S5 551 
(A) Immunofluorescence analysis of PHOX2B-GFP and ASCL1 expression in d12 SAP cells 552 
derived from axial progenitors as shown in Fig. 5A. (B) Immunofluorescence analysis of 553 
PRPH and HOXC9 expression in sympathetic neurons derived from axial progenitors as 554 
shown in Fig. 5A. 555 
 556 
Table S1. Significantly up- and downregulated transcripts, GO enrichment and TF 557 
signatures from RNAseq analysis 558 
Table S2. List of genes upregulated in different NC populations and GO enrichment analysis 559 
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Table S3. List of transcription factors shared between different NC populations 560 
Table S4. List of all genes up- and down-regulated in indicated NC populations and their 561 
progenitors. 562 
Table S5. List of primers 563 
 564 
METHODS 565 
Cell culture and differentiation 566 
We employed the following hPSC lines: a Shef4-derived Sox2-GFP reporter hESC line (44), 567 
the H9-derived SOX10-GFP (15) and PHOX2B-GFP (18) reporter hESC lines, the MSGN1-568 
VENUS reporter hiPSC line, and the unmodified Mastershef7 hESC line (44) and an iPSC 569 
line (MIFF-1) derived from a healthy individual (85). The MSGN1-Venus reporter line was 570 
generated by Transposon mediated BAC transgenesis using protocols described by (86). In 571 
brief, a human BAC (RP11-12L16) with piggyBac transposon repeats flanking the bacterial 572 
backbone and with Venus inserted directly after the initiating methionine of MSGN1 was 573 
transfected together with a piggyBac Transposase into NCRM1 iPSCs. Cells were cultured 574 
in feeder-free conditions in either Essential 8 (Thermo Fisher) or mTeSR1 (Stem Cell 575 
Technologies) medium on laminin 521 (Biolamina) or vitronectin (Thermo Fisher). All 576 
differentiation experiments were carried out in at least three different hPSC line. For 577 
NMP/axial progenitor differentiation hPSCs were dissociated using PBS/EDTA and plated at 578 
a density of 55,000 cells/cm2 (density optimised for 12-well plates) on fibronectin (Sigma) or 579 
vitronectin (Thermo Fisher)-coated wells, directly into NMP-inducing medium containing 580 
CHIR99021 (Tocris), FGF2 (20 ng/ml, Peprotech) and ROCK inhibitor Y-27632 for the first 581 
only day (10 µM, Tocris). We observed some variation in terms of induction of T+SOX2+ 582 
NMPs both between hPSC lines and also batches of CHIR99021 and thus the concentration 583 
of the latter was varied between 3-4 µM. BMP inhibition was carried out using LDN193189 584 
(Tocris) at 100 nM. For trunk NC differentiation day 3 hPSC-derived axial progenitors were 585 
dissociated using accutase and re-plated at a density 30,000 cells /cm2 on Geltrex (Thermo 586 
Fisher)-coated plates directly into NC-inducing medium containing DMEM/F12 (Sigma), 1x 587 
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N2 supplement (Thermo Fisher), 1x Non-essential amino acids (Thermo Fisher) and 1x 588 
Glutamax (Thermo Fisher), the TGFb/Nodal inhibitor SB431542 (2 µM, Tocris), CHIR99021 589 
(1 µM, Tocris), DMH1 (1 µM, Tocris),  BMP4 (15 ng/ml, Thermo Fisher) and  Y-27632 (10 590 
µM, Tocris). The medium was replaced at days 5 and 7 of differentiation but without the 591 
ROCK inhibitor and trunk NC cells were analysed either at day 8 or 9. For cranial neural 592 
crest differentiation hPSCs were dissociated using accutase and plated under the same NC-593 
inducing conditions as described above for 5-6 days. For posterior cranial/vagal/cardiac NC 594 
generation d4 differentiated anterior NC progenitors induced as described above were 595 
treated with retinoic acid (1 µM, Tocris) in the presence of the NC-inducing medium till day 6 596 
of differentiation. For sympathoadrenal progenitor (SAP) differentiation d8 trunk NC cells 597 
were re-suspended at a density of 200-300,000 cells /cm2 on Geltrex (Thermo Fisher)-598 
coated plates directly into medium containing BrainPhys neuronal medium (Stem Cell 599 
Technologies), 1x B27 supplement (Thermo Fisher), 1x N2 supplement (Thermo Fisher), 1x 600 
Non-essential amino acids (Thermo Fisher) and 1x Glutamax (Thermo Fisher), BMP4 (50 601 
ng/ml, Thermo Fisher), recombinant SHH (C25II) (50 ng/ml, R&D) and purmorphamine 602 
(1.25-1.5 µM, Millipore) and cultured for 4 days (d12 of differentiation).  For further 603 
sympathetic neuron differentiation d12 SAP cells were switched into a medium containing 604 
BrainPhys neuronal medium (Stem Cell Technologies), 1x B27 supplement (Thermo Fisher), 605 
1x N2 supplement (Thermo Fisher), 1x Non-essential amino acids (Thermo Fisher) and 1x 606 
Glutamax (Thermo Fisher), ascorbic acid (200 µM, Sigma) , NGF (10 ng/ml, Peprotech), 607 
BDNF (10 ng/ml, Peprotech) and GDNF (10 ng/ml, Peprotech) and cultured for a further 6-8 608 
days. For paraxial mesoderm differentiation d3 axial progenitor cultures were treated with 609 
accutase and replated at a density of 45,000/cm2  on 12-well Geltrex-coated plates in N2B27 610 
containing FGF2 (40 ng/ml, Peprotech) and CHIR99021 (8 µM, Tocris) for two days. For 611 
neural differentiation d3 axial progenitor cultures were treated with accutase and replated at 612 
a density of 45,000/cm2 on 12-well Geltrex-coated plates in N2B27 containing 100 nM 613 
retinoic acid (Tocris) for 2-3 days. 614 
RNA sequencing 615 
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Sample preparation 616 
For RNA sequencing we employed hESCs or axial progenitors following culture on 617 
fibronectin in FGF2 (20 ng/ml) and CHIR99021 (3 µM). Total RNA from NMPs and hESCs 618 
was harvested using the RNeasy kit (Qiagen) according to the manufacturer’s instructions. 619 
Library preparation/sequencing 620 
Total RNA was processed according to the TruSeq protocol (Illumina). Three separate RNA 621 
libraries (biological replicates) were barcoded and prepared for hPSCs and D3 axial 622 
progenitors. Library size, purity and concentration were determined using the Agilent 623 
Technologies 2100 Bioanalyzer. For sequencing, four samples were loaded per lane on an 624 
Illumina Genome Analyzer Hiseq2500. 625 
RNAseq quality control and mapping 626 
The quality of raw reads in fastq format was analyzed by FastQC 627 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Adapter contamination and poor 628 
quality ends were removed using Trim Galore v. 0.4.0 (Babraham Bioinformatics - Trim 629 
Galore! Available at: http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/). 630 
Single-end clean reads were aligned to the human reference genome (hg38 assembly) using 631 
Tophat2 v2.0.13 (87).  632 
RNA seq data analysis 633 
Read alignments were sorted with SAMtools v1.1 before being counted to genomic features 634 
by HTSeq version 0.6.0 (88). The average overall read alignment rate across all samples 635 
was 94.3%. Differential gene expression was performed using DESeq2 version 1.16.1 (89). 636 
in R version 3.3.3. Genes were considered significantly differentially expressed (DE) with a 637 
Benjamini-Hochberg adjusted pvalue <=0.05 and a log2FoldChange> |1|. Gene Ontology 638 
(GO) biological processes (BP) enrichment analysis was carried out for DE genes using the 639 
DAVID gene ontology functional annotation tool (https://david.ncifcrf.gov/) 640 
(90, 91) with default parameters. We considered as significant terms having a FDR adjusted 641 
pvalue <= 0.05, which is derived from a modified Fisher’s exact test. 642 
 643 
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Microarrays 644 
Sample preparation and processing 645 
Samples were prepared according to the Affymetrix WT Plus protocol for Gene Chip ® 646 
Whole Transcript Expression Arrays. Briefly 200ng of high quality total RNA, (RNA integrity 647 
number (RIN) greater than 9), was converted to double stranded cDNA with the introduction 648 
of a T7 polymerase binding site. This allowed the synthesis of an antisense RNA molecule 649 
against which a sense DNA strand was prepared. The RNA strand was digested and the 650 
resulting single stranded DNA fragmented and biotin labelled. Along with appropriate 651 
controls the labelled fragmented DNA was hybridised to Affymetrix Clariom D arrays 652 
overnight using the Affymetrix 640 hybridisation oven; 16 hours with rotation at 60 rpm at 653 
450C. The arrays were washed and stained according to standard protocols which allowed 654 
the introduction of streptavidin-phycoerythrin in order to generate a fluorescent signal from 655 
the hybridised biotinylated fragments. The washed and stained arrays were scanned using 656 
the Affymetrix 3000 7G scanner with autoloader. The generated CEL files were taken 657 
forward for analysis. 658 
Data analysis 659 
Data were analysed using the Affymetrix Transcriptome Analysis Console 4.0 software. 660 
Analysis of Expression (Gene+Exon) was used to generate lists of all differentially 661 
expressed genes showing >2; <-2 fold Log Change and P<0.05. For the distance matrix 662 
(Figure S4A), Exploratory Grouping analysis was used.  Log2 normalised intensity data 663 
values were mapped in R using the package ‘pheatmap’ with correlation clustering by gene. 664 
Gene ontology analysis was carried out using the ToppGene suite 665 
(https://toppgene.cchmc.org/enrichment.jsp) (92). Area proportional 3-Venn diagrams were 666 
drawn using the eulerApe software (93). 667 
Quantitative real time PCR 668 
Total RNA from different samples was harvested using the RNeasy kit (Qiagen) according to 669 
the manufacturer’s instructions and digested with DNase I (Qiagen) to remove genomic 670 
DNA. First strand cDNA synthesis was performed using the Superscript III system (Thermo 671 
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Fisher) using random primers. Quantitative real time PCR was carried out using the Applied 672 
Biosystems QuantStudio™ 12K Flex thermocycler together with the Roche UPL system. 673 
Primer sequences are shown in Table S5. 674 
Flow cytometry 675 
Cells were lifted into a single cell suspension using Accutase (as previously described) and 676 
resuspended in FACS buffer (DMEM with 10% v/v FCS) to neutralise Accutase before 677 
centrifugation at 1100rpm/4min. Cells were then resuspended in FACs buffer at 1x106 678 
cells/ml and 100,000 cells were placed in FACs tubes (Falcon 352053). A GFP baseline was 679 
set using unmodified wild type control cells. 680 
Immunofluorescence 681 
Cells were fixed for 10 minutes at 4°C in 4% paraformaldehyde (PFA) in phosphate buffer 682 
saline (PBS), then washed in PBST (PBS with 0.1% Triton X-100) and treated with 0.5 M 683 
glycine/PBST to quench the PFA. Blocking was then carried for 1-3 h in PBST supplemented 684 
with 3% donkey serum/1% BSA at room temperature or overnight at 40C. Primary and 685 
secondary antibodies were diluted in PBST containing in PBST supplemented with 3% 686 
donkey serum/1% BSA. Cells were incubated with primary antibodies overnight at 4°C and 687 
with secondary antibodies at room temperature for 2 h in the dark. Cell nuclei were 688 
counterstained using Hoechst 33342 (1:1000, Thermo Fisher) and fluorescent images were 689 
taken using the InCell Analyser 2500 system (GE Healthcare). We used the following 690 
antibodies: anti-T (1∶200; AF2085, R&D), anti-SOX2 (1:200; ab92494, Abcam), anti-SOX9 691 
(1:200; 82630, CST), anti-SNAI2 (1:400; C19G7, CST), anti-PAX3 (1:50; DSHB), anti-692 
phosphoSMAD1/5/9 (1:100; D5B10, CST), anti-SOX10 (1:200; D5V9L, CST), anti-SOX1 693 
(1:100; AF3369, R&D), anti-TBX6 (1:50, AF4744, R7D) anti-TH (1:1000; T1299, SIGMA), 694 
HOXC9 (1:50; ab50839, Abcam)  anti-PRPH (1:100; AB1530, Millipore), anti-CDX2 (1:200; 695 
ab76541, Abcam), anti-ASCL1 (1:100; 556604, BD Pharmigen), anti-GATA3 (1:100; sc-269, 696 
Santa Cruz), anti-GFP (1:1000; ab13970, Abcam), anti-ISL1 (1:100, DSHB), anti-PHOX2B 697 
(1:100; sc-376997, Santa Cruz). Images were processed using Photoshop and Fiji. Nuclear 698 
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segmentation followed by single cell fluorescence quantification was performed as described 699 
previously using Fiji and the MultiCell3D application as described previously (35, 94).  700 
Data availability 701 
The microarray and RNAseq data have been deposited to GEO (GSE109267 and 702 
GSE110608).  703 
 704 
 705 
 706 
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